The United States

George Clinical now has substantial operations in the USA, with 42 staff and leaders in oncology trials both operationally and scientifically.

George Clinical in The United States

Tweet about this on TwitterShare on FacebookShare on LinkedIn

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, Czech Republic and now the USA.

Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.

George Clinical now has substantial operations in the USA, with 42 staff and leaders in oncology trials both operationally and scientifically. We are here to support our US customers with their CRO needs and to lead oncology trials across our core operational facilities in the Asia Pacific region.

George Clinical US News

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s Pharma Services (CRO) Division…

Breastfeeding may reduce a mother’s heart attack and stroke risk

Breastfeeding is not only healthy for babies, it may also help to reduce mothers’ risk of having a heart attack or stroke later in life, according to new research published in today’s issue of Journal of the American Heart Association, the Open Access Journal of the American...

Study settles debate over head position following stroke

Download the study results presented by Professor Craig Anderson at the AHA / ASA International Stroke Conference, Houston, 22 February 2017. (PPTX 1.4MB)

Major study heralds new era in treatment of type 2 diabetes: results available

Download the results of the CANVAS study, presented at the American Diabetes Association Conference 2017. (PDF 3MB)

Top Australian honour for founders

In the 2017 Queen's Birthday Honours List, Professors Robyn Norton and Stephen MacMahon, the founders and principal directors of The George Institute for Global Health, were appointed Officers in the General Division of the Order of Australia (AO).

World Health Assembly adopts major sepsis resolution

Sepsis, one of the most prevalent but misdiagnosed, deadly diseases has been established as a global priority by the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).

UNSW Sydney and The George Institute affiliation marks new era in Australian health research

The George Institute Principal Director, Professor Stephen Macmahon

Details

Number of Personnel: 45
In-country Services: Business Development
Scientific Leadership
Oncology specialists
Project Management
Clinical Operations
Clinical Compliance
Regulatory Services
Medical and Safety management
Data Management
Statistics
Health Economics
Population: 321 million
Official Language: English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9%
Hospital Records Language: English

Twitter Facebook LinkedIn